Skip to content

Cost-effectiveness of Extracorporeal Life Support Treatment

A Multicenter Prospective Observational Cohort Study Determining the Cost-effectiveness of Extracorporal Life Support (ECLS) Treatment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02837419
Enrollment
200
Registered
2016-07-19
Start date
2017-12-01
Completion date
2020-01-01
Last updated
2019-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill

Keywords

extracorporeal life support, health related quality of life

Brief summary

This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.

Detailed description

A direct comparison between usual care and ECLS treatment is difficult. Alternatively we compare predicted mortality for every patient based on validated scoring systems at the initiation of ECLS treatment with the actual outcome, so every patient is his own control. Primary outcome is HRQoL assessed with the EQ-5D questionnaire at 1 year. Healthcare costs and costs from a societal perspective are prospectively measured.

Interventions

BEHAVIORALHealth related Quality of life EQ-5D

Quality of Care

Sponsors

University Medical Center Groningen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted to intensive care * Treated with extracorporeal life support

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
health related quality of life12 monthshealth related quality of life with EQ-5D questionnaire at 6 and 12 months

Countries

Netherlands

Contacts

Primary ContactWim Dieperink, PhD
w.dieperink@umcg.nl+31503619838

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026